BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2291142)

  • 1. [Chromosomal changes in 60 patients with acute myeloblastic leukemia. Frequency, characteristics and prognostic significance].
    del Potro E; Ferro MT; Martínez R; Alarcón C; Villegas A; Asenjo S; Morales D; Espinós D; Díaz Mediavilla J; Alvarez Carmona A
    Sangre (Barc); 1990 Oct; 35(5):345-51. PubMed ID: 2291142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
    Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
    Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of the chromosomal findings in acute myeloid leukemia with maturation (M2)].
    Nakamura H; Sadamori N; Sasagawa I; Itoyama T; Tokunaga S; Sato T; Yao E; Ichimaru M; Kohno T; Oyakawa Y
    Rinsho Ketsueki; 1989 Jun; 30(6):806-14. PubMed ID: 2795891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
    Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
    Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
    Chillón CM; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; Rodríguez MJ; Rodríguez-Salazar MI; Corrales A; Calmuntia MJ; Orfão A; González M; San Miguel JF
    Haematologica; 2001 Feb; 86(2):162-6. PubMed ID: 11224485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
    Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
    Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic study of 130 patients with acute nonlymphocytic leukemia.
    Michalová K; Musilová J; Zemanová Z
    Neoplasma; 1990; 37(3):283-91. PubMed ID: 2370915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytogenetic abnormality and prognosis in childhood acute myeloblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
    Katano N; Tsurusawa M; Hirota T; Horikoshi Y; Mimaya J; Iwai T; Kaneko Y; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Aug; 38(8):647-56. PubMed ID: 9311270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.
    Cortes JE; Kantarjian HM; O'Brien S; Giles F; Keating MJ; Freireich EJ; Estey EH
    Cancer; 1999 Apr; 85(7):1506-13. PubMed ID: 10193940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
    Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461.
    Marcucci G; Mrózek K; Ruppert AS; Archer KJ; Pettenati MJ; Heerema NA; Carroll AJ; Koduru PR; Kolitz JE; Sterling LJ; Edwards CG; Anastasi J; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Jun; 22(12):2410-8. PubMed ID: 15197203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
    Guo Y; Xue Y; Xie X; Wu D; Li J; Lu D; Jiang F; Geng M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):72-5. PubMed ID: 10751523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working Parties.
    Grimwade D; Walker H; Oliver F; Wheatley K; Clack R; Burnett A; Goldstone A
    Bone Marrow Transplant; 1997 Jun; 19(11):1117-23. PubMed ID: 9193755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of 32 cases of acute leukemia with abnormality of chromosome 7].
    Lu Y; Jin J; Chen ZM; Lou JY; Xu WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):596-9. PubMed ID: 15583990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities in human acute nonlymphocytic leukemia: relationship to age, sex, and exposure to mutagens.
    Rowley JD
    Natl Cancer Inst Monogr; 1982; 60():17-23. PubMed ID: 6956808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.
    Testoni N; Borsaru G; Martinelli G; Carboni C; Ruggeri D; Ottaviani E; Pelliconi S; Ricci P; Pastano R; Visani G; Zaccaria A; Tura S
    Haematologica; 1999 Aug; 84(8):690-4. PubMed ID: 10457403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.